Arrhythmogenic right ventricular cardiomyopathy

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a disease of the heart muscle. A US government genetics page says part of the muscle wall breaks down over time, which raises the chance of an abnormal heartbeat and of sudden death. The page says it usually appears in adulthood, may cause no symptoms in its early stages, and can in later stages lead to heart failure. MeSH, by contrast, calls it a congenital cardiomyopathy, in which fatty and fibrous tissue grows into the wall of the right ventricle as muscle cells are lost; the two descriptions are given side by side.

Also called ARVC · Arrhythmogenic right ventricular dysplasia

  • Condition
  • In this atlas

Overview

Technical summary

MeSH descriptor D019571 (Arrhythmogenic Right Ventricular Dysplasia, exact), last updated 2013-07-08, filed under cardiomyopathies. MeSH calls it a congenital cardiomyopathy, while the MedlinePlus Genetics page (last updated February 2018) says it usually appears in adulthood; the two statements are kept side by side and are not reconciled here. The genetics page estimates that ARVC occurs in 1 in 1,000 to 1 in 1,250 people, says it can result from mutations in at least 13 genes, and says up to half of all cases appear to run in families. Symptoms it lists when they occur are palpitations, light-headedness and fainting. No testing steps, treatment, activity limits or family advice is recorded. It carries no clinical review.

Recognition

A US government genetics page says that when symptoms occur they most commonly include a sensation of fluttering or pounding in the chest (palpitations), light-headedness and fainting (syncope).

Burden

No burden claims are published.

Claims and evidence

No claims are published for this condition yet.

Record details

Record id
cardio:arrhythmogenic-right-ventricular-cardiomyopathy
Content hash
a15d6b2d4c612bd3bab8580c8fcb7d668516e33721a103fe3523502881f7e23f